RecruitingNot applicableNCT07251933
A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple Countries
Studying Hereditary angioedema
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Takeda
- Principal Investigator
- Study DirectorTakeda
- Intervention
- No intervention(other)
- Enrollment
- 40 enrolled
- Eligibility
- 2-11 years · All sexes
- Timeline
- 2026 – 2026
Study locations (20)
- Hospital de Ninos Sor Maria Ludovica, La Plata, Buenos Aires, Argentina
- Centro de Alergia e Inmunologia Clinica Mar del Plata, Mar del Plata, Buenos Aires, Argentina
- Hospital de Pediatria S.A.M.I.C.- Prof. Dr. Juan P. Garrahan, Ciudad de Buenos Aires, Buenos Aires F.D., Argentina
- Hospital Italiano de Buenos Aires, Buenos Aires, Ciudad Autonoma de BuenosAires, Argentina
- Sanatorio de la Canada-Cordoba, Córdoba, Argentina
- AP-HM- Hopital de La Timone, Marseille, Bouches-du-Rhone, France
- CHU de Grenoble Alpes - Hopital Couple-Enfant, La Tronche, Grenoble, France
- AP-HP - Hopital Armand Trousseau, Paris, France
- Universitatsklinikum Ulm, Ulm, Baden-Wurttemberg, Germany
- Universitatsklinikum Frankfurt am Main, Frankfurt am Main, Hesse, Germany
- Hamophilie Zentrum Rhein Main GmbH, Frankfurt am Main, Hesse, Germany
- Universitatsklinikum Munster, Münster, North Rhine-Westphalia, Germany
- Universitatsklinikum Leipzig, Leipzig, Saxony, Germany
- Klinikum St. Georg Leipzig, Leipzig, Saxony, Germany
- Universitaetsklinikum Schleswig-Holstein - Campus Luebeck, Lübeck, Schleswig-Holstein, Germany
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07251933 on ClinicalTrials.govOther trials for Hereditary angioedema
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07298447Donidalorsen Treatment in Children With Hereditary AngioedemaIonis Pharmaceuticals, Inc.
- RECRUITINGNANCT07559630Single-center Randomized Controlled Trial of Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidSJessica K. Stewart, MD
- RECRUITINGPHASE3NCT07428499Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)ADARx Pharmaceuticals, Inc.
- ENROLLING BY INVITATIONPHASE3NCT07204938A Long-Term Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.
- RECRUITINGPHASE3NCT06960213STOP-HAE: A Phase 3 Study of ADX-324 in HAEADARx Pharmaceuticals, Inc.
- RECRUITINGNANCT07001280A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)CSL Behring
- RECRUITINGPHASE3NCT06842823A Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.
- RECRUITINGPHASE4NCT06806657Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to GaradacimabCSL Behring